Elisabeth Aslangul

Summary

Country: France

Publications

  1. ncbi Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial
    Elisabeth Aslangul
    Universite Paris Descartes, France
    AIDS 24:77-83. 2010
  2. ncbi [Role of corticosteroids in infectious disease]
    Elisabeth Aslangul
    Hotel Dieu, Service de Medecine Interne, 75004 Paris, France
    Presse Med 41:400-5. 2012
  3. ncbi Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis
    Elisabeth Aslangul
    EA 3964, Faculté de Médecine de l Université Paris 7, 46, rue Henri Huchard, 75870 Paris Cedex 18, France
    Antimicrob Agents Chemother 50:3615-21. 2006
  4. ncbi [Diagnosing asthenia and chronic fatigue syndrome]
    Elisabeth Aslangul
    , , 75004 Paris
    Rev Prat 55:1029-33. 2005
  5. ncbi Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine
    Serge Perrot
    Service de Medecine Interne et Consultation de la Douleur, Hotel Dieu, 1 Place du Parvis Notre Dame, 75004 Paris, France
    Int J Colorectal Dis 22:1119-21. 2007
  6. ncbi [Self-medication]
    Claire Le Jeunne
    , , , 75004 Paris, France
    Rev Prat 58:1585-9. 2008
  7. ncbi High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors
    Elisabeth Aslangul
    Universite Paris Descartes, France
    AIDS 25:1128-31. 2011
  8. ncbi [Eye and corticosteroid's use]
    Audrey Fel
    Assistance Publique Hopitaux de Paris, Hotel Dieu, Universite Paris Descartes, Service de Medecine Interne, 75004 Paris, France
    Presse Med 41:414-21. 2012
  9. ncbi Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient
    Serge Perrot
    Hopital Hotel Dieu, Medecine Interne, Universite Paris Descartes, Paris, France
    J Clin Rheumatol 15:72-4. 2009
  10. ncbi Relationship between the level of acquired resistance to gentamicin and synergism with amoxicillin in Enterococcus faecalis
    Elisabeth Aslangul
    EA9933, , , USA
    Antimicrob Agents Chemother 49:4144-8. 2005

Detail Information

Publications10

  1. ncbi Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial
    Elisabeth Aslangul
    Universite Paris Descartes, France
    AIDS 24:77-83. 2010
    ..Pravastatin is recommended for patients with protease inhibitor-associated dyslipidemia. Rosuvastatin is the statin most effective on low-density lipoprotein cholesterol (LDL-c) in non-HIV patients...
  2. ncbi [Role of corticosteroids in infectious disease]
    Elisabeth Aslangul
    Hotel Dieu, Service de Medecine Interne, 75004 Paris, France
    Presse Med 41:400-5. 2012
    ..The duration of the prescription of corticosteroids must be reduced to a minimum during sepsis...
  3. ncbi Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis
    Elisabeth Aslangul
    EA 3964, Faculté de Médecine de l Université Paris 7, 46, rue Henri Huchard, 75870 Paris Cedex 18, France
    Antimicrob Agents Chemother 50:3615-21. 2006
    ..Our data are compatible with acquisition of intermediate-level gentamicin resistance by uptake impairment in E. faecalis...
  4. ncbi [Diagnosing asthenia and chronic fatigue syndrome]
    Elisabeth Aslangul
    , , 75004 Paris
    Rev Prat 55:1029-33. 2005
  5. ncbi Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine
    Serge Perrot
    Service de Medecine Interne et Consultation de la Douleur, Hotel Dieu, 1 Place du Parvis Notre Dame, 75004 Paris, France
    Int J Colorectal Dis 22:1119-21. 2007
    ..Pericarditis is rarely reported in inflammatory bowel disease. Besides its common causes, pericarditis could be related to ulcerative colitis flare or to 5-aminosalicylic acid (5-ASA) treatment...
  6. ncbi [Self-medication]
    Claire Le Jeunne
    , , , 75004 Paris, France
    Rev Prat 58:1585-9. 2008
  7. ncbi High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors
    Elisabeth Aslangul
    Universite Paris Descartes, France
    AIDS 25:1128-31. 2011
    ..A 45-day course of either statin reduced the median CRP level from 3.0 to 2.4 mg/l (P < 0.001) with no correlation with changes in lipid parameters...
  8. ncbi [Eye and corticosteroid's use]
    Audrey Fel
    Assistance Publique Hopitaux de Paris, Hotel Dieu, Universite Paris Descartes, Service de Medecine Interne, 75004 Paris, France
    Presse Med 41:414-21. 2012
    ..When administered topically, only 5% of the delivered dose is absorbed by the anterior segment, distribution is almost zero in the middle and posterior segments of the eye...
  9. ncbi Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient
    Serge Perrot
    Hopital Hotel Dieu, Medecine Interne, Universite Paris Descartes, Paris, France
    J Clin Rheumatol 15:72-4. 2009
    ..Several factors that increased the renal toxicity of tenofovir included low body mass index, concomitant use of nonsteroidal anti-inflammatory agents, and other antiretroviral drugs, including ritonavir...
  10. ncbi Relationship between the level of acquired resistance to gentamicin and synergism with amoxicillin in Enterococcus faecalis
    Elisabeth Aslangul
    EA9933, , , USA
    Antimicrob Agents Chemother 49:4144-8. 2005
    ..Therefore, the use of an MIC of 500 microg/ml as a clinical cutoff limit to predict in vivo benefit of the combination remains a simple and effective tool...